Suberythemic and erythemic doses of a 308-nm excimer laser treatment of stable vitiligo in combination with topical tacrolimus: A randomized controlled trial

J Am Acad Dermatol. 2020 Nov;83(5):1463-1464. doi: 10.1016/j.jaad.2020.03.009. Epub 2020 Aug 28.

Authors

Jung Min Bae¹, Soo Hyun Kwon², Hyun Jeong Ju¹, Hee Young Kang³

Affiliations

¹ Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
² Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.
³ Department of Dermatology, Ajou University School of Medicine, Suwon, Korea. Electronic address: hykang@ajou.ac.kr.

PMID: 32171812
DOI: 10.1016/j.jaad.2020.03.009

No abstract available

Publication types

Equivalence Trial
Letter
Randomized Controlled Trial

MeSH terms

Administration, Topical
Combined Modality Therapy
Erythema
Female
Humans
Lasers, Excimer / therapeutic use*
Male
Middle Aged
Tacrolimus / administration & dosage*
Vitiligo / therapy*

Substances

Tacrolimus